Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Anemia, Refractory, with Excess of Blasts 1

Interventions

ponatinib 3asciminib 3nilotinib 2fludarabine phosphate 2Whole-Body Irradiation 2Specimen Handling 2Melphalan 2Dasatinib 2Cyclophosphamide 2Busulfan 2venetoclax 1ruxolitinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1letermovir 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Stem Cell Transplantation 1Sirolimus 1Rituximab 1Pharmaceutical Preparations 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Interviews as Topic 1Imatinib Mesylate 1Etoposide 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Chronic-Phase × Cord Blood Stem Cell Transplantation × 90 days × Clear all
NCT02727803 2026-05-22

Personalized NK Cell Therapy in CBT

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡